Catriona Yale, Chief Development Officer: Akero Therapeutics AKRO Sell · Filed 25/01/31

Trade details

Type: Insider sale
Amount: $1,558,926.8
Shares · price: 27,340 sh · $57.02 a share
Held after: 95,648 sh
Stock: Akero Therapeutics AKRO
Person: Catriona YaleChief Development Officer
Trade date: 25/01/27
Filed: 25/01/31
Days to filing: 4 days

Sold 22.2% of holdings

Share of holding sold: 22.2%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/28~25/02/26

Catriona Yale's recent trades

Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$28.4K
659 sh
$28.4K
Filed 25/09/12
Traded 25/09/11
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$457.7K
8,658 sh
$457.7K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$71.8K
1,342 sh
$71.8K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$89.6K
1,633 sh
$89.6K
Filed 25/06/20
Traded 25/06/18
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$334K
6,210 sh
$334K
Filed 25/06/20
Traded 25/06/16

Catriona Yale, Chief Officer — sold $1.6M of Akero Therapeutics AKRO · 22.2% of holdings · 10b5-1 plan | Whalegun